MapLight Therapeutics, Inc. (MPLT) stock
MPLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.57−0.33 (-4.78%)
Close on Nov 17, 2026Market cap $304.70MP/E –Yield –
MapLight Therapeutics total assets
Total assets on the balance sheet at the end of each period.
MapLight Therapeutics's total assets was $368.35M at Jun 30, 2026. For fiscal 2025 it was $479.51M, up 250.2% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $479.51M | +250.2% |
| FY2024 | Dec 31, 2024 | $136.92M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $368.35M | +169.0% |
| Q1 FY2026 | Mar 31, 2026 | $418.79M | – |
| Q4 FY2025 | Dec 31, 2025 | $479.51M | – |
| Q3 FY2025 | Sep 30, 2025 | $257.22M | – |
| Q4 FY2024 | Dec 31, 2024 | $136.92M | – |
See a number that looks wrong?